Keros Therapeutics director Charles W. Newton sells 551 common shares worth $5,675.3

• Keros Therapeutics director Charles W. Newton sold 551 shares of common stock on Aug. 18, 2026.
• Sale priced at USD 10.3 per share on a weighted-average basis.
• Direct holdings fell to 12,114 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001866219-26-000010), on August 20, 2026, and is solely responsible for the information contained therein.